Investors
Information Disclosure
-
VOLUNTARY ANNOUNCEMENT - CATEGORY I INNOVATIVE MEDICINE "TDI01" OBTAINED APPROVAL FOR COVID-19 CLINICAL TRIAL2022.09.26
-
VOLUNTARY ANNOUNCEMENT SHARE - PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.09.23
-
VOLUNTARY ANNOUNCEMENT - ENTERING INTO LICENSE AGREEMENT2022.09.22
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.09.20
-
VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO RESTRICTED SHARE AWARD SCHEME2022.09.19
-
NEXT DAY DISCLOSURE RETURN2022.09.16
-
NEXT DAY DISCLOSURE RETURN2022.09.07
-
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 20222022.09.01